Botanical species · safety record
Salsola kali
The EFSA Compendium of Botanicals holds 11 constituent measurements and 1 adverse-effect record for Salsola kali. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Salsola kali L.
Regulatory presence
No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.
What the records describe
Constituents measured
- 3,4-dihydroxybenzoic acid2
- Oxalates2
- Oxalic acid2
- P-coumaric acid2
- Estrone1
- Salsolidine1
- Salsoline1
Plant parts
- Aerial part of plants4
- Unspecified4
- Live plants2
- Roots and other underground parts2
Preparations
- Solvent extraction5
Effect types
- Digestive1
Target tissues
- Digestive: pancreas1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| 3,4-dihydroxybenzoic acid | Aerial part of plants | Solvent extraction | — | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | No resolvable identifier |
| 3,4-dihydroxybenzoic acid | Roots and other underground parts | Solvent extraction | — | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | No resolvable identifier |
| Estrone | Aerial part of plants | — | — | Gelpermeation, High Performance Thin Layer Chromatography (HPTLC) | No resolvable identifier |
| Oxalates | Unspecified | — | ≥ 5 Percent | — | No resolvable identifier |
| Oxalates | Unspecified | — | ≤ 15.7 Percent | — | No resolvable identifier |
| Oxalic acid | Unspecified | — | ≤ 10.7 Percent | — | No resolvable identifier |
| Oxalic acid | Unspecified | — | ≥ 2 Percent | — | No resolvable identifier |
| P-coumaric acid | Aerial part of plants | Solvent extraction | — | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | No resolvable identifier |
| P-coumaric acid | Roots and other underground parts | Solvent extraction | — | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | No resolvable identifier |
| Salsolidine | Live plants | — | — | — | No resolvable identifier |
| Salsoline | Live plants | — | — | — | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Digestive | Digestive: pancreas | Aerial part of plants | Solvent extraction | — | In vitro | Resolve DOI |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Mathams, R. H., Sutherland, A. K. The oxalate content of some Queensland pasture plants. Queensland journal of agricultural science, 1952, vol. 9, p. 317-34.
- Tundis, R., Loizzo, M. R., Statti, G. A., Menichini, F. Inhibitory effects on the digestive enzyme alpha-amylase of three Salsola species (Chenopodiaceae) in vitro . Pharmazie, 2007, vol. 62, no. 6, p. 473-475. DOI
- Sokolowska-Krzaczek, Anna., Skalicka-Wozniak, Krystyna., Czubkowska, Katarzyna. VARIATION OF PHENOLIC ACIDS FROM HERB AND ROOTS OF SALSOLA KALI L.. Acta societatis botanicorum poloniae, 2009, vol. 78, no. 3, p. 197-201.
- Wassel, G. M., Baghdadi, H. H., El Difrawy, S. M. Phyto-ecdysone from some wild Egyptian Salsola species. Fitoterapia, 1979, vol. 50, no. 2, p. 51-2.
- Krylov, Yu. F. Comparative action of Salsola kali alkaloids salsoline and salsolidine. Sb. nauchn. tr., ryzansk. med. inst., 1962, vol. 15, p. 45-9.
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.